leadf
logo-loader
viewTonix Pharmaceuticals

Proactive One2One Virtual Event - Tonix Pharmaceuticals

Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP) CEO Seth Lederman presents to investors at Proactive's One2One Virtual Event.

Tonix is a New York-based, clinical-stage biopharmaceutical company focused on discovering and developing small molecules and biologics to treat psychiatric, pain and addiction conditions.

Quick facts: Tonix Pharmaceuticals

Price: 0.91 USD

NASDAQ:TNXP
Market: NASDAQ
Market Cap: $240.95 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Tonix Pharmaceuticals named herein, including the promotion by the Company of Tonix Pharmaceuticals in any Content on the Site, the Company...

FOR OUR FULL DISCLAIMER CLICK HERE

Tonix Pharmaceuticals forms second research collaboration with Massachusetts...

Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) CEO Dr Seth Lederman tells Proactive the clinical-stage biopharmaceutical company has signed a second research collaboration agreement with Massachusetts General Hospital. Dr Lederman says while the first collaboration is centered on heart...

4 days, 11 hours ago

2 min read